Immediate Effect of Johnstone's Pressure Splint Added to Stretching on the Spasticity in Cerebrovascular Disease.

NCT ID: NCT03675958

Last Updated: 2018-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-24

Study Completion Date

2019-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

TITLE: Immediate effect of Johnstone's Pressure Splint added to Stretching on the spasticity of elbow flexors and wrist in Cerebrovascular Disease (CVD).

INTRODUCTION: In the rehabilitation of the upper limb post-CVD to employed exercise modalities such as stretching (S) to control spasticity, improve mobility and functionality. Also it is used the Johnstone´s Pressure Splint (JPS), which exerts circumferential pressure and contribute to spastic pattern inhibition, sensory re-education and increased of the mobility.

OBJECTIVE: The aim of the study is to evaluate the immediate effect of JPS added to S on the spasticity of elbow flexors and wrist, the reflex excitability and the joint kinematics in Stroke.

MATERIALS AND METHODS: A randomized experimental study with two intervention groups will be performed. Control group (GS): Stretching and experimental group: (GJPS + S): JPS plus S. Measurement times: Before the intervention (T0) and immediately post- intervention (T1). The outcome variables are muscle tone of elbow, wrist and hand assessed with the Modified Ashworth Scale (MAS); H reflex of the Flexor Carpi Radialis muscle, latency (ms), duration (ms) and amplitude (mV) of the M and H waves, and the amplitude the Hmax / Mmax ratio (%). Shoulder, elbow and trunk angles (degrees), trunk displacement (cm) and duration (sec) of the Functional Reach Pattern (PAF) will be evaluated with the software Contemplas.

ANALYSIS: Descriptive statistics will be applied and Shapiro Wilk test to evaluate the normality of the variables. Intra-group differences will be assessed with the student t-test paired and intergroup with the student t-test unpaired or the sum of Wilcoxon rank according to the distribution of the variables.

EXPECTED RESULTS: Hypotheses and contributions to the scientific evidence on the immediate effect of the S and JPS will be generated, to support the JPS as a complement to the traditional treatment. The results will be socialized in an international scientific event and a publication will be submitted to an impact journal.

KEY WORDS: Spasticity, H Reflex, Johnstone's Pressure Splint, Stretching, Functional Reach.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spasticity as Sequela of Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A randomized experimental study with two intervention groups will be performed. Control group (GS): Stretching and experimental group: (GJPS + S): Johnstone´s Pressure Splint plus Stretching.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators
The evaluator does not know the assignment of the participants to the intervention group.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GJPS + S

Experimental group: (GJPS + S) : Application Johnstone´s Pressure Splint plus Stretching in in 4 different treatment postures.

Group Type EXPERIMENTAL

Johnstone's Pressure Splint

Intervention Type OTHER

the intervention consists in the application of two tools used for the treatment of spasticity post - CVD. Johnstone's Pressure Splint added Stretching

Stretching

Intervention Type OTHER

the intervention consists in the application of one tool used for the treatment of spasticity post - CVD. Just Stretching

GS

Control group (GS): Just Stretching in 4 different treatment postures.

Group Type ACTIVE_COMPARATOR

Stretching

Intervention Type OTHER

the intervention consists in the application of one tool used for the treatment of spasticity post - CVD. Just Stretching

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Johnstone's Pressure Splint

the intervention consists in the application of two tools used for the treatment of spasticity post - CVD. Johnstone's Pressure Splint added Stretching

Intervention Type OTHER

Stretching

the intervention consists in the application of one tool used for the treatment of spasticity post - CVD. Just Stretching

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medical diagnosis of CVD.
* Minimum evolution time from 6 months to 48 months.
* Muscular tone according to the Modified Ashworth Scale\> a 1+ in the elbow and wrist flexors.
* Maintain seated position without human support or assistance for at least 10 seconds and maintain standing position for more than 30 seconds to perform transfers from one surface to another.

Exclusion Criteria

* Altered cognitive ability, assessed through the "Short Portable Mental State Questionnaire".
* Application of botulinum toxin within six (6) months prior to participation in the study.
* Patients with skin lesions, lacerations or allergies.
* People with pacemaker.
* People in whom the H reflex can not be evoked.
* Pain and hyperalgesia in the upper limb.
* Peripheral vascular disease in upper limb.
* Fractures, or musculoskeletal injuries in the paretic upper limb less than a year old.
* Osteoarthritis, rheumatoid arthritis and clinical conditions associated with acute pain, inflammation, and moderate to severe decrease in joint mobility.
* Consumption of drugs such as Baclofen, benzodiazepines, or muscle relaxants such as dantrolene and tizanidine.
* Ingestion of caffeine and alcohol 12 hours before evaluations.
Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Industrial de Santander

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

María Juliana González Silva

Physiotherapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maria Juliana González Silva

Role: PRINCIPAL_INVESTIGATOR

Universidad Industrial de Santander

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maria Juliana González Silva

Role: CONTACT

(057) + 3166208712

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UISantander

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.